PharmaZac is one of the most dynamic pharmaceutical firms in Greece and an important player in manufacturing, exports and healthcare.

Research & Development

PharmaZac is investing more than 15% of its annual income on new products, technologies and infastructure.


We understand how a modern Pharmaceutical company should function. PharmaZac provides a full array of services from Sales, Marketing and Business Development to Distribution & Logistics.


PharmaZac offers a wide range of more than 90 products in the therapeutic areas of Cardiology, Oncology, CNS, Urology, Dermatology, Contrast Media, Antibiotics & Orthopaedics.

Latest News
  • Pharmazac launched the new product Abelfiz / aripiprazole 10, 15 and 30mg in hard tablets  for the treatment of schizophrenia in adults and in adolescents aged 15 years and older, for the treatment of moderate to severe manic episodes in bipolar I disorder and for......

  • Pharmazac participates in CPhI 2018....

  • Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of Petasitis Hybridus in liquid hard gelatin capsules of 70,4 mg P A free, under the trade name Petagran. Petagran / Petasitis hybridus is effective in reducing......

  • Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor. Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and the pain sings of inflammation associated with acute gouty arthritis....


Years of Research & Development


Business Units


European Awards


Global Certifications

Memberships & Awards

  • Pharmazac is a proud member of the Hellenic Pharmaceutical Industry Association with an active intervention in policy making and regulatory changes.
  • Pharmazac is regularly inspected by the Authorities and International Clients for its logistics, distribution and wholesale commercial best practices. In 2016 the company’s GDP has been renewed.
  • As a permanent member of the Generics Association Pharmazac has joined the working committees and is an active participant.
  • The implementation of Good Manufacturing Practice is certified by local and international authorities while a robust QA system suns through the company’s operations.
  • Pharmazac first received an ISO Certificate in 1997 and has been audited without interruption since then.
  • Pharmazac is a regular member of Hellenic Association of Pharmaceutical Companies


We are getting bigger
Are you interested in working in an awarded pharmaceutical company?